title: Head and neck extranodal non-Hodgkin's lymphomas in Indian patients.
abstract: Though radiotherapy has traditionally been the treatment of the choice for the patients with localised extranodal lymphomas of the head and neck areas, its adequacy as the sole modality of treatment has come to be questioned. The disease is shown to relapse in other distant extranodal sites especially the gastrointestinal tract. The addition of systemic chemotherapy has been suggested. Fifty-five patients with localised head and neck extranodal lymphomas were treated at the Tata Memorial Hospital during the period 1976-1982, 35 with radiation therapy alone and 20 with combination therapy. The total survival at 5 years was 65% for patients treated with radiation alone and 85% for those treated with combination therapy. The 5 year disease-free survival dropped to 45% for the former group but was 74% for the latter group. This difference was statistically significant (p less than 0.01). We infer that localised extranodal lymphomas be regarded as a systemic disease and be treated by a multimodal approach.
authors.affiliation: Department of Radiation Oncology, Tata Memorial Hospital, Bombay, India.
authors.forename: S K
authors.initials: SK
authors.lastname: Shrivastava
authors.forename: J V
authors.initials: JV
authors.lastname: Moni
authors.forename: K A
authors.initials: KA
authors.lastname: Dinshaw
authors.forename: S H
authors.initials: SH
authors.lastname: Advani
authors.forename: R
authors.initials: R
authors.lastname: Gopal
authors.forename: C N
authors.initials: CN
authors.lastname: Nair
authors.forename: T
authors.initials: T
authors.lastname: Saikia
authors.forename: A M
authors.initials: AM
authors.lastname: Borges
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging